TREM2 Agonistic Antibody Enhances Microglial Clearance of Amyloid-Beta and Restores Synaptic Plasticity
Study Design & Technical Specifications
Sample Size / Cohort
Documented in primary study
Subject / Study Model
Human Clinical Cohort
Analytical Modalities
Primary Abstract & Repository Description
Source: AlzforumEditorial Critique, Methodological Value & Reusability Guide
1. Scientific Context & Premise
Primary Premise (Alzforum): "Preclinical and Phase 1 biomarker readouts for novel TREM2-targeted monoclonal antibodies show sustained microglial metabolic reprogramming." Within Alzheimer's Disease (AD), this work examines TREM2, Microglia, Immunotherapy, Therapeutics Tracker in relation to Aβ42/40, p-tau217, p-tau181, GFAP, NfL, and APOE ε4 genotype interactions. Authored by Alzforum Therapeutics Tracker Team.
2. Study Architecture & Findings
Study Architecture: Human Clinical Cohort (primary study cohort) utilizing CSF Biomarkers, PET Imaging. Key reported conclusion: "Preclinical and Phase 1 biomarker readouts for novel TREM2-targeted monoclonal antibodies show sustained microglial metabolic reprogramming."
3. Secondary Analysis & Reusability
Secondary Analysis Applications: (1) Cross-referencing CSF Biomarkers, PET Imaging variables (TREM2, Microglia, Immunotherapy, Therapeutics Tracker) against open repositories in Alzheimer's Disease (AD); (2) Benchmarking feature distributions and effect sizes reported in "TREM2 Agonistic Antibody Enhances Microglial Clearance of Amyloid-Beta and Resto"; (3) Informing cohort stratification and endpoint selection.
4. Methodological Caveats & Governance
Methodological Note: When integrating these CSF Biomarkers, PET Imaging findings, account for cohort-specific inclusion criteria (primary study cohort), potential site/instrument batch effects, and repository license terms (open_access).
Data Access, Reproducibility & Analysis Starter Guide
BIDS (Brain Imaging Data Structure) v1.9+
Quick Data Access & Structured Export
Open the primary repository directly or download structured metadata (JSON / CSV) in one click.
This neuroimaging resource follows the Brain Imaging Data Structure (BIDS) specification, organizing raw NIfTI volumes (.nii.gz), acquisition parameters (.json sidecars), and participant phenotype tables (participants.tsv) in a deterministic directory hierarchy.
Tags & Modalities
Related Alzheimer's & Dementia Research & Datasets
Explore All DatasetsAgora Target Validation: INPP5D (inositol polyphosphate-5-phosphatase D) in Alzheimer’s Disease
This gene is a member of the inositol polyphosphate-5-phosphatase (INPP5) family and encodes a protein with an N-terminal SH2 domain, an inositol phosphatase domain, and two C-terminal protein interaction domains. Expression of this protein is restricted to hematopoietic cells where its movement from the cytosol to the...
OpenNeuro ds004504: Multimodal MRI & PET Repository for Early Alzheimer’s Disease and Mild Cognitive Impairment (BIDS)
An exceptional multimodal neuroimaging repository providing 3T structural MRI, resting-state fMRI, and [18F]Florbetapir Amyloid-PET scans from 180 subjects formatted strictly to BIDS standard. This open dataset serves as a benchmark resource for deep learning and diagnostic biomarker discovery in early Alzheimer's and MCI.
Agora Target Validation: NRN1 (neuritin 1) in Alzheimer’s Disease
This gene encodes a member of the neuritin family, and is expressed in postmitotic-differentiating neurons of the developmental nervous system and neuronal structures associated with plasticity in the adult. The expression of this gene can be induced by neural activity and neurotrophins. The encoded protein contains a ...
Agora Target Validation: BIN1 (bridging integrator 1) in Alzheimer’s Disease
This gene encodes several isoforms of a nucleocytoplasmic adaptor protein, one of which was initially identified as a MYC-interacting protein with features of a tumor suppressor. Isoforms that are expressed in the central nervous system may be involved in synaptic vesicle endocytosis and may interact with dynamin, syna...
Allen Brain Atlas: Multi-plane optical physiology during image change detection
Time series of behavioral variables and neural activity measured with multi-plane in vivo 2-photon imaging in mice performing a visual change detection task where mice were trained with image set A and tested with a novel image set B... Freely accessible open data product maintained by the Allen Institute for Brain Science.
Agora Target Validation: HTRA1 (HtrA serine peptidase 1) in Alzheimer’s Disease
This gene encodes a member of the trypsin family of serine proteases. This protein is a secreted enzyme that is proposed to regulate the availability of insulin-like growth factors (IGFs) by cleaving IGF-binding proteins. It has also been suggested to be a regulator of cell growth. Variations in the promoter region of ...
Active Clinical Trials & Pipeline in Alzheimer's & Dementia
View Clinical PipelineRelated Data & Resources
Academic Research & Medical Information Disclaimer
This page provides structured scientific metadata, methodological critiques, and open-data reusability guidelines intended strictly for neuroscience researchers and data scientists. It does not constitute medical advice, clinical diagnosis, or treatment recommendations.
Was this resource helpful?
Help improve data curation by sharing your feedback.